-
Int J Clin Pharmacol Res · Jan 2001
Lack of antagonism between nicorandil and sulfonylurea in stable angina pectoris.
- N Hata, M Takano, T Kunimi, H Kishida, and T Takano.
- Department of Internal Medicine, Nippon Medical School, Inbagun, Chiba, Japan. hata-n@nms.ac.jp
- Int J Clin Pharmacol Res. 2001 Jan 1;21(1):59-63.
AbstractThe aim of this study was to clarify whether or not nicorandil (a potassium channel opener) caused adverse reactions in patients with angina pectoris who also had diabetes mellitus treated with sulfonylurea (a potassium channel inhibitor). Nineteen diabetic patients with angina pectoris were enrolled, eight were treated with glibenclamide (group A) and 11 were not (group B). Treadmill exercise testing and frequency of anginal attacks were used to evaluate the severity of angina pectoris. Blood sugar and hemoglobin A1c were measured for evaluation of diabetes mellitus control. Exercise tolerance, frequency of anginal attacks and diabetes mellitus control were not perturbed by treatment in either group. In conclusion, there were no antagonistic reactions from the combination of nicorandil with sulfonylurea in angina pectoris complicated by diabetes mellitus.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..